TY - JOUR
T1 - Pretreatment factors associated with symptomatic stroke in Moyamoya disease patients
T2 - A multicenter study
AU - Musmar, Basel
AU - Roy, Joanna M.
AU - Salim, Hamza Adel
AU - Kaul, Anand
AU - Atallah, Elias
AU - Naamani, Kareem El
AU - Chen, Ching Jen
AU - Jabre, Roland
AU - Saad, Hassan
AU - Grossberg, Jonathan A.
AU - Dmytriw, Adam A.
AU - Patel, Aman B.
AU - Khorasanizadeh, Mirhojjat
AU - Ogilvy, Christopher S.
AU - Thomas, Ajith J.
AU - Monteiro, Andre
AU - Siddiqui, Adnan
AU - Cortez, Gustavo M.
AU - Hanel, Ricardo A.
AU - Porto, Guilherme
AU - Spiotta, Alejandro M.
AU - Piscopo, Anthony J.
AU - Hasan, David M.
AU - Ghorbani, Mohammad
AU - Weinberg, Joshua
AU - Nimjee, Shahid M.
AU - Bekelis, Kimon
AU - Salem, Mohamed M.
AU - Burkhardt, Jan Karl
AU - Zetchi, Akli
AU - Matouk, Charles
AU - Howard, Brian M.
AU - Lai, Rosalind
AU - Du, Rose
AU - Abbas, Rawad
AU - Sioutas, Georgios S.
AU - Amllay, Abdelaziz
AU - Munoz, Alfredo
AU - Herial, Nabeel A.
AU - Tjoumakaris, Stavropoula I.
AU - Gooch, Michael Reid
AU - Rosenwasser, Robert H.
AU - Jabbour, Pascal
N1 - Publisher Copyright:
© 2024 Elsevier Ltd
PY - 2024/12
Y1 - 2024/12
N2 - Objectives: Moyamoya disease (MMD) is a cerebrovascular disorder marked by the progressive steno-occlusion of the bilateral internal carotid arteries and the formation of abnormal collateral vessel networks at the base of the brain. Previous studies have attempted to identify risk factors predictive of postoperative complications to improve patient management. This study aims to identify pretreatment factors associated with post-bypass symptomatic strokes in MMD patients. Methods: This study is a multicenter retrospective analysis conducted across 13 academic institutions in North America. A total of 518 patients with MMD were included. Data collected included patient demographics, disease characteristics, and follow-up duration. Stroke-free survival was analyzed using Kaplan-Meier curves. Univariate and multivariable Cox regression analyses were used to identify risk factors for symptomatic stroke. Results: The median age of the patients was 43 years (IQR, 34–52 years), and 370 (71 %) were females. Multivariable Cox regression identified advanced age (HR 1.03, 95 % CI 1.01–1.05, p = 0.011), female sex (HR 2.03, 95 % CI 1.00–4.11, p = 0.049), diabetes mellitus (HR 2.03, 95 % CI 1.14–3.63, p = 0.016), smoking status (HR 2.27, 95 % CI 1.27–4.05, p = 0.006), and asymptomatic disease (HR 0.37, 95 % CI 0.15–0.93, p = 0.034) as significant factors associated with symptomatic stroke. Conclusion: Advanced age, female sex, diabetes mellitus, and smoking status were significant predictors of symptomatic stroke in MMD patients after bypass surgery. Asymptomatic patients had a reduced risk of stroke. These findings emphasize the importance of managing modifiable risk factors and the potential benefits of early detection in improving clinical outcomes for MMD patients. Further prospective studies are needed to validate these findings.
AB - Objectives: Moyamoya disease (MMD) is a cerebrovascular disorder marked by the progressive steno-occlusion of the bilateral internal carotid arteries and the formation of abnormal collateral vessel networks at the base of the brain. Previous studies have attempted to identify risk factors predictive of postoperative complications to improve patient management. This study aims to identify pretreatment factors associated with post-bypass symptomatic strokes in MMD patients. Methods: This study is a multicenter retrospective analysis conducted across 13 academic institutions in North America. A total of 518 patients with MMD were included. Data collected included patient demographics, disease characteristics, and follow-up duration. Stroke-free survival was analyzed using Kaplan-Meier curves. Univariate and multivariable Cox regression analyses were used to identify risk factors for symptomatic stroke. Results: The median age of the patients was 43 years (IQR, 34–52 years), and 370 (71 %) were females. Multivariable Cox regression identified advanced age (HR 1.03, 95 % CI 1.01–1.05, p = 0.011), female sex (HR 2.03, 95 % CI 1.00–4.11, p = 0.049), diabetes mellitus (HR 2.03, 95 % CI 1.14–3.63, p = 0.016), smoking status (HR 2.27, 95 % CI 1.27–4.05, p = 0.006), and asymptomatic disease (HR 0.37, 95 % CI 0.15–0.93, p = 0.034) as significant factors associated with symptomatic stroke. Conclusion: Advanced age, female sex, diabetes mellitus, and smoking status were significant predictors of symptomatic stroke in MMD patients after bypass surgery. Asymptomatic patients had a reduced risk of stroke. These findings emphasize the importance of managing modifiable risk factors and the potential benefits of early detection in improving clinical outcomes for MMD patients. Further prospective studies are needed to validate these findings.
KW - Moyamoya
KW - Multicenter
KW - Risk factors
KW - Stroke
UR - https://www.scopus.com/pages/publications/85209251801
U2 - 10.1016/j.jocn.2024.110922
DO - 10.1016/j.jocn.2024.110922
M3 - Article
C2 - 39571479
AN - SCOPUS:85209251801
SN - 0967-5868
VL - 130
JO - Journal of Clinical Neuroscience
JF - Journal of Clinical Neuroscience
M1 - 110922
ER -